The University recently entered into a partnership that will benefit its researchers in teaming up with the medical industry to translate new research discoveries into therapeutic treatments and cures.
Pitt researchers in the School of Medicine will be able to connect with pharmaceutical and medical companies to service their research needs through an enterprise agreement with Scientist.com, the world's leading marketplace for outsourced scientific services.
“Scientist.com’s award-winning marketplace will enable thousands of pharmaceutical and biotech researchers to access the outstanding suite of translational research services in Pitt’s School of Medicine,” said Rebecca Bagley, vice chancellor for economic partnerships. “It is critical that industry and academia work together to lower barriers to innovation and bring new cures to market.”
The School of Medicine will be the first entity within Pitt to provide translational research services through Scientist.com. The University has created a centralized operation with a combination of academic and industrial experience to help its research facilities deliver outstanding basic science services to the medical industry.
Through Scientist.com, Pitt will create mutually beneficial, long-lasting partnerships with industry by providing fee-for-service access to its expert faculty and facilities. Scientist.com will serve as a time-saving liaison to match Pitt researchers with medical and pharmaceutical companies seeking research help on various projects such as new drug therapies, bioinformatics or testing new medical supplies through a one-stop-shop database. Pitt’s research resources provide access to expertise, technology applications and state-of-the-art instruments that are otherwise unavailable to industry and many academic investigators.
Likewise, Pitt researchers can reach out to companies through Scientist.com to provide research expertise.
Pitt holds important places in history for translational medical research, including being the birthplace of the first successful polio vaccine developed by Jonas Salk and being the research hub for Thomas Starzl, “the father of modern transplantation.”
"The School of Medicine is a hotbed of clinical and translational research," said Arthur S. Levine, the John and Gertrude Petersen Dean of the School of Medicine. "Our faculty researchers have broad and deep scientific expertise, and we support their work with robust research infrastructure and a commitment to developing innovative tools and technologies. We also have a long track record of working with industry partners to speed the translation of scientific discoveries to the clinic and to the marketplace. I'm excited to see more such collaborations emerge from this partnership.”